Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as ...

Geneva: The World Health Organization (WHO) has issued a global safety alert highlighting the risk of non-arteritic anterior ischemic optic neuropathy (NAION) associated with the use ...

The new arrangement could cut patients' copays to $25 per month, or less, for Wegovy, Zepbound, Ozempic and Rybelsus ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also ...

The number of people poisoned by the incorrect use of weight loss medication is on the rise in the Netherlands. Last year, ...

As Healio previously reported, oral semaglutide reduced risk for major adverse CV events (MACE) by 14% in high-risk adults with type 2 diabetes (HR = 0.86; 95% CI, 0.77-0.96; P = .0006 ...